Hepatitis B Virus Reactivation in a Primary Central Nervous System Lymphoma Patient following Intrathecal Rituximab Treatment

Publisher： Karger

E-ISSN： 1421-9662|125|3|121-124

ISSN： 0001-5792

Source： Acta Haematologica, Vol.125, Iss.3, 2010-12, pp. : 121-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab with high‐dose methotrexate in primary central nervous system lymphoma

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : 1149-1154

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combined Treatment with High-Dose Methotrexate, Vincristine and Procarbazine, without Intrathecal Chemotherapy, Followed by Consolidation Radiotherapy for Primary Central Nervous System Lymphoma in Immunocompetent Patients

By  

Oncology, Vol. 60, Iss. 2, 2001-02 ,pp. : 134-140

Karger

Access to resources Recommend Favorite

Fatal Reactivation of Occult Hepatitis B Virus Infection after Rituximab and Chemotherapy in Lymphoma: Necessity of Antiviral Prophylaxis

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 537-539

Karger

Access to resources Recommend Favorite

Primary Central Nervous System Lymphoma in the Elderly

By  

Oncology Research and Treatment, Vol. 37, Iss. 7-8, 2014-07 ,pp. : 376-377

Karger

Access to resources Recommend Favorite

Reactivation of hepatitis B virus during treatment with hydroxyurea in an elderly patient with essential thrombocythemia

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 15, Iss. 6, 2015-06 ,pp. : 812-813

John Wiley & Sons Inc

Access to resources Recommend Favorite